Status:
RECRUITING
Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients with Sarcopenia
Lead Sponsor:
The Third Affiliated hospital of Zhejiang Chinese Medical University
Conditions:
Sarcopenia
Eligibility:
All Genders
60-95 years
Phase:
NA
Brief Summary
Introduction: The efficacy of existing therapies for the treatment of sarcopenia is still not satisfactory. Therefore, this randomized controlled, assessor-blinded study was designed to investigate th...
Detailed Description
Introduction: The efficacy of existing therapies for the treatment of sarcopenia is still not satisfactory. Therefore, this randomized controlled, assessor-blinded study was designed to investigate th...
Eligibility Criteria
Inclusion
- 60 years ≤ age ≤ 95 years, male or female;
- Patients are able to walk and communicate independently, and can complete required rehabilitation training;
- Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS);
- Patients volunteer to participate in this study and sign the informed consent.
Exclusion
- Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system;
- Patients with severe mental illness, cognitive impairment, and disorientation;
- Patients have trauma and unsuitable for sports;
- Patients with electronic devices or metal objects implanted in the body;
- Patients can't complete the required rehabilitation training;
- Patients cannot receive EA treatment due to any reasons
- Patients are participating in other drugs, acupuncture and massage trials.
Key Trial Info
Start Date :
July 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05431010
Start Date
July 2 2022
End Date
December 31 2026
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China